WUXI06:BKK
Wuxi Biologics (Cayman) Inc. KKPS DR
5,20 THB
0,00%
(0,00) 1J
15 oct., 16:40:00 UTC+7 · THB
search
Tous les symboles
| Symbole | Cours | Variation | % variat. |
|---|
insights_autoGénération des principaux insights pour WUXI06...
Ouverture
5,25 THB
Élevé
5,35 THB
Faible
5,05 THB
Cap. boursière
200,24 Md
Vol. moyen
93,60 k
Volume
288,50 k
+ haut sur 1 an
6,25 THB
+ bas sur 1 an
3,02 THB
Actions en circulation
4,12 Md
Nombre d'employés
15 k
Ouverture
5,25 THB
Élevé
5,35 THB
Faible
5,05 THB
Cap. boursière
200,24 Md
Vol. moyen
93,60 k
Volume
288,50 k
+ haut sur 1 an
6,25 THB
+ bas sur 1 an
3,02 THB
Actions en circulation
4,12 Md
Nombre d'employés
15 k
Articles
Sources : Web et partenaires du secteur de l'information
Quartz en Français
·
il y a 29 minutes
Les contrats à terme sur le Nasdaq baissent de 1,1 % alors que les préoccupations concernant les dépenses en IA pèsent sur la technologie.
Zonebourse Suisse
·
il y a 11 minutes
S&P 500 - Les actions à suivre jeudi : CoreWeave, Intel, Marvell, Western Digital, Apple
ABC Bourse
·
il y a 12 minutes
S&P 500 - Les actions à suivre jeudi: CoreWeave, Intel, Marvell, Western Digital, Apple
Zonebourse
·
il y a 22 minutes
Les puces vont-elles rebondir à Wall Street ?
Profil
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
À propos de Wuxi Biologics (Cayman) Inc. KKPS DR